CoChat

Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities

Abdu, Tarig A. M., Neary, Richard, Elhadd, Tarik A., Akber, Mohamed, Clayton, Richard N. · 2001 · Clinical Endocrinology
Cited by 120

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

BACKGROUND Hypopituitarism in adults is associated with increased vascular mortality, which has been attributed to GH deficiency. OBJECTIVE To compare the lipid profile and coronary risk predicted by the Framingham Heart Study equation in GH‐deficient hypopituitary patients and healthy age and gender‐matched controls. DESIGN A cross‐sectional observational study. METHODS We studied 50 adult‐onset growth hormone deficient hypopituitary patients (23F, 27M), on appropriate conventional hormone replacement and 45 controls (22F, 23M) matched for age, gender and smoking habit. The subjects (age range 30–75 years) were free from diabetes, hypertension, ischaemic heart disease (IHD) and peripheral vascular disease. All hypogonadal male patients were on testosterone replacement therapy. A similar proportion of female patients (8/23) and controls (7/22) were on HRT. Body mass index (BMI), waist–hip ratio (WHR) and blood pressure were recorded. After an overnight fast blood glucose, total‐cholesterol, triglycerides, HDL‐cholesterol, apolipoproteins A‐I, B and Lp (a) were measured. Coronary risk was calculated for each individual from age, gender, systolic blood pressure, total and HDL cholesterol, smoking habit and presence of diabetes and left ventricular hypertrophy using the Framingham equation. RESULTS BMI and WHR were significantly increased in GHD hypopituitary adults of both sexes, but to a greater extent in females. Triglycerides were elevated in both sexes. Total and LDL‐cholesterol were increased in both sexes (significantly only in males), and HDL cholesterol and apo A‐I were lower (significantly only in females). The reduction in HDL cholesterol was correlated negatively with adiposity (BMI), particularly when centrally distributed (WHR) in patients and controls. LDL cholesterol did not correlate to adiposity but higher levels were present in GH‐deficient subjects. The total to HDL cholesterol ratio was significantly increased in patients of both genders (P = 0·002). There were no differences in the apolipoproteins B and Lp(a) between patients and controls. Absolute risk (mean ± SEM) of a fatal or non‐fatal coronary event during the next 5 years was significantly greater in GHD hypopituitary patients than control subjects (4·82 ± 0·73% vs. 2·94 ± 0·53, P = 0·04). Cardiovascular risk relative to the local population (RR) was significantly higher in GHD hypopituitary adults (RR = 1·43 CL 1·06–1·80, P = 0·011) but not in the control group (1·08 CL 0·59–1·6). When divided by gender, RR for male patients was not increased (1·14 CL 0·83–1·45, P = 0·096). However, female patients had significantly higher RR (1·7 CL 1·05–2·5, P = 0·048). The RR for male and female controls was not different from the local population. CONCLUSION Changes in lipid levels help to explain the results from risk factor modelling which show increased coronary risk in growth hormone deficient hypopituitary patients, particularly females. The abnormal lipid profile is characterized in both genders by an increase in the total to HDL cholesterol ratio, an important parameter in the Framingham equation, and is related to growth hormone deficiency either directly (LDL) or indirectly. The lipid abnormalities conferring increased risk appear to be through increased central obesity (HDL). Adverse calculated coronary risk might provide a new objective indication for consideration of GH replacement therapy in adults.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.2001.01320.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 120

Metadata

Authors
Abdu, T. A. M., Neary, R., Elhadd, T. A., Akber, M., & Clayton, R. N.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2001-08
Volume
55
Issue
2
Pages
209-216
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2077091806
Cited by
120
References
6
FWCI
3.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities. https://app.cochat.ai/papers/10.1046/j.1365-2265.2001.01320.x
The paper
Abdu, T. A. M., Neary, R., Elhadd, T. A., Akber, M., & Clayton, R. N. (2001). Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2001.01320.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.